Abu Dhabi Designates Three Breast Cancer Centers of Excellence
Abu Dhabi designates three breast cancer centers of excellence to strengthen specialized care across the emirate. Burjeel Cancer…
Drug targets iron to curb overproduction in blood disorder
Researchers explore how rusfertide, an iron-regulating drug, may curb red blood cell overproduction in polycythemia vera patients by…
CAR T-Cell Therapy Outcomes Consistent Across Site Types
CAR T-cell therapy outcomes show consistency across academic and community sites, with aligned toxicities and response rates.
Risankizumab Outperforms Deucravacitinib in Moderate Plaque Psoriasis
risankizumab psoriasis study shows the drug clears skin in over 50% of moderate plaque patients after 16 weeks,…
AI adoption gains traction in oncology practices
AI adoption gains traction in oncology practices with AI tools reducing administrative tasks.
Vitiligo Patients Advised on Repigmentation Timeline Expectations
Vitiligo patients need realistic repigmentation timeline expectations, as results take months to years, not weeks, according to Dr.…
AI Tool Forecasts Diabetes Complications
New AI tool forecasts diabetes complications in patients, helping prevent heart disease and kidney disease risks.
Stem cell donors getting younger and better
Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…
Clinical Trial Joining: The Hurdles You Need to Know
Discover the hurdles of clinical trial joining and how to overcome them with ease and success in medical…
Public weighs in on opioid funds and work rules
New Mexico struggles to spend $100M in opioid funds due to workforce shortages and procurement delays, delaying critical…